Latest Data & Signals Issued
|Signal Type||Signal Value||Data|
|Score||-5.148||7 days ( 5.56 % )|
|Last Price||$2.04||-0.97 %|
|High/ Low||$2.03 - $2.11||0.488%|
|Chg 7 Days||-2.86 %||$2.10 $2.04|
|Chg 30 Days||-9.33 %||$2.25 $2.04|
|Chg 12 mos||-44.11 %||$3.65 $2.04|
|Trend - 3 mos||-21.47 %||Width: 19.74 %|
|Trend - 12 mos||12.83 %||Width: 116.23 %|
|Pred. range - 3 mos||$1.51 - $1.81||-25.75 % - -11.09 %|
|Pred. range - 12 mos||$2.04 - $4.40||-0.186 % - 115.82 %|
|Short mv avg 3 mos||Sell||2023-08-28 - 17 days|
|Long mv avg 3 mos||Buy||2023-08-23 - 20 days|
|Short/Long mv avg 3 mos||Sell||2023-07-26 - 40 days|
|Short mv avg 12 mos||Sell||2023-08-28 - 17 days|
|Long mv avg 12 mos||Sell||2023-07-25 - 41 days|
|Short/Long mv avg 12 mos||Sell||2023-08-07 - 32 days|
|Pivot Short||Sell||2023-08-24 - 19 days|
|Bollinger||Buy||2023-09-01 - 13 days|
|MACD||Sell||No Dates Stored For This Signal|
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.
Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.
Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
Moving Average (7d)
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.